DEF: Envista Holdings Schedules 2026 Annual Meeting

Envista Holdings Corporation announced its 2026 Annual Meeting of Stockholders, scheduled for May 19, 2026, to elect directors, ratify auditors, and vote on executive compensation.

Summary

• Envista Holdings Corporation is holding its 2026 Annual Meeting of Stockholders on May 19, 2026, virtually.
• The meeting will cover four main items of business: election of eight director nominees, ratification of Ernst & Young LLP as the independent auditor, an advisory vote on executive compensation, and an advisory vote on the frequency of future executive compensation votes.
• Stockholders of record as of March 23, 2026, are eligible to vote.
• The company reported 2025 total sales of $2.7 billion, with net income of $47.0 million and adjusted EBITDA of $371.7 million.
• The filing details executive compensation for 2025, including base salaries, annual incentives, and long-term equity awards, with a strong emphasis on performance-based compensation.
• Director nominees are presented with their qualifications, and the company highlights its corporate governance framework, including an independent board chairperson and independent committee members.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this filing as moderately positive, reflecting a company in a turnaround phase with improved financial performance in 2025, strong corporate governance practices, and high stockholder support for executive compensation, despite some performance metrics not being met for long-term incentives.

Positives

• Generated total sales of $2.7 billion in 2025.
• Achieved net income of $47.0 million in 2025, a significant improvement from a net loss of $1,118.6 million in 2024.
• Adjusted EBITDA increased to $371.7 million in 2025 from $296.1 million in 2024.
• Adjusted Diluted Earnings Per Share improved to $1.19 in 2025 from $0.73 in 2024.
• Free Cash Flow was $230.9 million in 2025.
• Employee engagement scores improved, with 73% of respondents reporting feeling engaged at work.
• Reduced safety incident rate by 13% in 2025.
• Donated $1.9 million in goods and services to support oral health initiatives through the Envista Smile Project.
• Strong stockholder support for executive compensation, with 94.3% approval in the 2025 Say on Pay vote.

Negatives

• Reported a net loss of $1,118.6 million in 2024.
• Free Cash Flow decreased to $230.9 million in 2025 from $302.8 million in 2024.
• The 2023-2025 Performance Stock Units (PSUs) did not pay out (0% of target) due to below-threshold performance.
• The company's stock price experienced a 5.3% decrease between the trading day prior to disclosure and the trading day following disclosure for certain executive awards granted on February 25, 2024.

Risks

• The filing does not explicitly detail new or emerging risks beyond standard corporate governance and compensation disclosures.
• Potential future challenges could arise from the competitive landscape in the dental products industry, though not specifically detailed as a risk in this filing.

Future Outlook

The filing does not contain specific forward-looking financial guidance but outlines the agenda for the 2026 Annual Meeting of Stockholders, which includes electing directors and approving executive compensation, indicating a focus on continued governance and operational execution.

Management Comments

• "Building on the momentum established across the second half of 2024, we continued to drive improvements across our three areas of priority—growth, operations, and people—as reflected in the following accomplishments."
• "Our success depends on our ability to attract, develop and retain a talented employee base. We aspire to help our employees thrive both personally and professionally."
• "We are dedicated to building a world-class culture of engagement."
• "We believe that belonging is a cornerstone of an energizing employee culture, and we strive to cultivate a sense of connection, authenticity, and acceptance throughout our Company."
• "Our Board of Directors recognizes that enhancing and protecting long-term value for our stockholders requires a robust framework of corporate governance that serves the best interests of all our stockholders."
• "We believe that the separation of the positions [Chairperson and CEO] best enables the Board to ensure that our businesses, risks, opportunities and affairs are managed effectively and in the best interests of our stockholders."

Industry Context

StockSavvy.ai notes that Envista Holdings Corporation operates in the global dental products industry, a sector characterized by innovation in digital imaging, orthodontics, and dental implants. The company's focus on a broad portfolio and global reach positions it among key players. The compensation practices detailed, particularly the emphasis on performance-based equity, align with trends in the healthcare and medical technology sectors where attracting and retaining top talent is crucial.

Comparison to Industry Standards

• Envista's peer group for executive compensation benchmarking includes companies like Align Technology, Inc., DENTSPLY SIRONA Inc., Henry Schein, Inc., and Teleflex Incorporated, which are significant players in the dental, medical device, and healthcare technology sectors.
• The company's Adjusted EBITDA margin of 13.7% in 2025 is presented in the context of its own historical performance and peer comparisons, though specific peer margin data is not provided in this filing.
• The 2025 Say on Pay vote received 94.3% approval, which is generally considered strong support and aligns with high approval rates seen in previous years, indicating general stockholder satisfaction with compensation practices compared to industry norms.

Corporate Governance

Related Party Transactions

• No transactions between the Company and any officer, director, or nominee for director, or any affiliate or related person, of the type or amount required to be disclosed under Item 404(a) of Regulation S-K since January 1, 2025.

Stakeholder Impact

• Shareholders: The election of directors, ratification of auditors, and advisory votes on executive compensation directly impact shareholder governance and oversight. Improved financial performance in 2025 may positively influence shareholder value.
• Employees: The company emphasizes attracting, developing, and retaining talent, with competitive compensation and benefits programs. Employee engagement scores are highlighted as a positive indicator.
• Management: Executive compensation is heavily weighted towards performance-based equity, aligning management's interests with long-term stockholder value creation. Base salary increases were implemented to address market gaps.

Next Steps

• Hold the 2026 Annual Meeting of Stockholders on May 19, 2026.
• Elect eight director nominees for one-year terms.
• Ratify the selection of Ernst & Young LLP as the independent registered public accounting firm for 2026.
• Conduct advisory votes on executive compensation and the frequency of future advisory votes.
• Continue to implement the company's turnaround strategy focused on growth, operations, and people.

Key Dates

Recommendation

The filing indicates a company in a turnaround phase with improved financial results in 2025, strong corporate governance, and high shareholder support for compensation practices. However, the lack of specific forward-looking guidance and the failure of certain long-term incentive plans to vest suggest a need for continued monitoring rather than an immediate strong buy or sell recommendation. A 'hold' position allows investors to observe the sustained execution of the turnaround strategy and future performance.

Keywords

Envista Holdings Corporation, Proxy Statement, Annual Meeting, Stockholders, Directors, Executive Compensation, Auditor Ratification, Corporate Governance, Equity Awards, Financial Performance